Joint Development Based on the Business Alliance with Otsuka Pharmaceutical
First written in FY2017. 3 of 4 entries say "Restated". Latest entry: FY2022.
The whole theme swung hardest in 2022: 1 of 7 companies on the "Worse" side.
1 other company's latest entry also says "Restated".
- FY2022RestatedAnnual report
「Under the business alliance agreement with Otsuka Pharmaceutical Co., Ltd., the two companies continue to consider joint development, focusing on areas in which they can complement each other.」
The companies continue to consider joint development under the business alliance with Otsuka Pharmaceutical. - FY2020RestatedAnnual report
「Under the business alliance agreement with Otsuka Pharmaceutical Co., Ltd., the two companies continue to consider joint development, focusing on areas in which they can complement each other.」
The companies continue to consider joint development based on the business alliance with Otsuka Pharmaceutical. - FY2018RestatedAnnual report
「Under the business alliance agreement with Otsuka Pharmaceutical Co., Ltd., the two companies continue to consider joint development, focusing on areas in which they can complement each other.」
The companies continue to consider joint development based on the business alliance with Otsuka Pharmaceutical. - FY2017First statedAnnual report
「Under the business alliance agreement with Otsuka Pharmaceutical Co., Ltd., the two companies continue to consider joint development, focusing on areas in which they can complement each other.」
The consideration of joint development in complementary areas based on the business alliance with Otsuka Pharmaceutical is described separately.